SLC3A2 and cancer: Amplifications in genes such as SLC3A2, OXSM, and GYS1 were linked to increased expression in cancer tissues, whereas genes such as NDUFS1 and NCKAP1 showed reduced expression, underscoring the diverse impact of DRG expression on BLCA pathology (Figure 1C, 1D).